Posted John Deo
byThomas Shrader from BTIG set a price target of $48 for NASDAQ:ARCT, indicating a significant potential upside
Source: Two Blokes Trading
Posted John Deo
byGoodRx's ROIC of 3.25% is significantly lower than its WACC of 11.62%, indicating inefficient capital utiliza
Source: Two Blokes Trading
Posted John Deo
byCSG Systems International, Inc. showcases efficient capital utilization with a ROIC of 12.11% and a WACC of 9
Source: Two Blokes Trading
Posted John Deo
byPerpetua Resources Corp. (NASDAQ:PPTA) is currently under investigation by Levi & Korsinsky for potential
Source: Two Blokes Trading
Posted John Deo
byMagnite's ROIC of 3.19% outperforms its closest peer, PubMatic, showcasing its effectiveness in generating re
Source: Two Blokes Trading
Posted John Deo
byWall Street anticipates an earnings per share (EPS) of $3.49 and revenue of approximately $3.77 billion for t
Source: Two Blokes Trading
Posted John Deo
byPlus Therapeutics, Inc. (NASDAQ:PSTV) stock surged by 311.4% following the FDA's Orphan Drug Designation for
Source: Two Blokes Trading
Posted John Deo
byPlus Therapeutics, Inc. (NASDAQ:PSTV) stock surged by 311.4% following the FDA's Orphan Drug Designation for
Source: Two Blokes Trading
Posted John Deo
byEarnings per Share (EPS) expected at -$0.35 with revenue projected at $16.6 million. The company's Price-to-E
Source: Two Blokes Trading
Posted John Deo
byEarnings per Share (EPS) expected at -$0.35 with revenue projected at $16.6 million. The company's Price-to-E
Source: Two Blokes Trading
Posted John Deo
byBarclays downgraded Vail Resorts, Inc. (NYSE:MTN) to "Underweight" with a modest stock price increase of 0.2%
Source: Two Blokes Trading
Posted John Deo
byGroupon, Inc. (NASDAQ:GRPN) is a prominent player in the e-commerce marketplace, connecting subscribers with l
Source: Two Blokes Trading